Skip to main content

Cannabis Compounds May Help Reverse Fatty Liver Disease

Published on June 23, 2026, 7:45 p.m.
Cannabis Compounds May Help Reverse Fatty Liver Disease

Topic: Health

Scientists have found that two non-intoxicating compounds in cannabis, CBD and CBG, may help reduce liver fat and improve metabolic health. This could lead to a new plant-based treatment for fatty liver disease.

Cannabis compounds CBD and CBG might help reverse fatty liver disease, a common chronic condition worldwide. Researchers from the Hebrew University of Jerusalem found that these non-intoxicating compounds can support the liver in two important ways.

Firstly, they increase the organ's ability to store backup energy. This helps liver cells maintain normal function even when exposed to metabolic stress like a high-fat diet. Secondly, CBD and CBG reactivate enzymes inside the cell that break down unwanted materials.

Fatty Liver Disease Affects One Third of Adults

Metabolic dysfunction associated steatotic liver disease (MASLD) is currently the most widespread chronic liver condition worldwide. It affects roughly one third of adults and is strongly linked to obesity, high blood pressure, and insulin resistance.

Doctors typically recommend lifestyle changes like improved diet and increased physical activity to manage the disease. However, maintaining these habits long-term can be challenging. There are very few approved medications available, which is why researchers are actively searching for new treatment options.

How CBD and CBG Improve Liver Energy Systems

Using advanced scientific tools, the researchers discovered that CBD and CBG do more than simply reduce fat accumulation. They appear to improve the internal functioning of liver cells through a process called 'metabolic remodeling'. One key discovery involved the liver's energy reserves. The compounds increased levels of phosphocreatine, a molecule that acts like an emergency energy supply.

Restoring the Liver's Cellular Cleanup Process

The study also showed that CBD and CBG reactivate cathepsins. These enzymes operate inside lysosomes, which serve as recycling centers within the cell. Their role is to break down unwanted materials so they can be removed. When cathepsin activity is restored, liver cells become better equipped to process and eliminate harmful fats and waste.

Different Metabolic Benefits From CBD and CBG

Although both compounds produced beneficial effects, the study found that they influence metabolic health in slightly different ways. CBD and CBG both helped stabilize blood sugar levels and improved how the body processes glucose. However, CBG produced stronger improvements in several metabolic markers.

A Potential New Plant-Based Treatment Path

The researchers emphasize that further studies are needed to determine how these findings may translate to human treatments. Additional research will help clarify whether these compounds could eventually be developed into therapies.

Why It Matters

This study highlights the potential for plant-based treatments to improve liver health, which is crucial in India where fatty liver disease is a growing concern among adults.

Key Facts

  • Fatty liver disease affects one third of adults worldwide
  • CBD and CBG are non-intoxicating compounds found in cannabis
  • The compounds increase the liver's ability to store backup energy
  • They also reactivate enzymes that break down unwanted materials in the liver
  • Further studies are needed to determine if these compounds can be developed into human therapies

Key Terms

Metabolic remodeling
A process by which CBD and CBG improve the internal functioning of liver cells

Implications

This study highlights the potential for plant-based treatments to improve liver health, which is crucial in India where fatty liver disease is a growing concern among adults.


Source: https://www.sciencedaily.com/releases/2026/03/260306145616.htm

Journal Reference:

  1. Radka Kočvarová, Shahar Azar, Bella Agranovich, Ifat Abramovich, Saveliy Kirillov, Alina Nemirovski, Saja Baraghithy, Inbar Plaschkes, Emmanuelle Merquiol, Alexander Rouvinski, Galia Blum, Liad Hinden, Joseph Tam. Cannabidiol and cannabigerol ameliorate steatotic liver disease via phosphocreatine buffering and lysosomal restoration. British Journal of Pharmacology, 5 March 2026 [abstract]

Leave a Comment

Name
Email
Body
... ...

Get Exclusive Insights

with Every Issue

JoinShalyamNewsletter

Stay ahead in education, research, and innovation—straight to your inbox.